← Back to Search

Opioid Analgesic

Opioids for Obstructive Sleep Apnea in Children

Phase < 1
Recruiting
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Intubation without medication (e.g. no propofol prior to intubation)
Requirement for airway instrumentation: LMA or ETT
Must not have
Pulmonary hypertension
Total intravenous anesthesia required
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end tidal co2 measured at each minute for 10 consecutive minutes following opioid administration
Awards & highlights
No Placebo-Only Group

Summary

This trial found that children with OSA have different responses to opioids depending on the degree of their intermittent hypoxemia.

Who is the study for?
This trial is for children aged 2 to 8 with obstructive sleep apnea who are undergoing tonsillectomy or adenotonsillectomy. They must have had a preoperative sleep study confirming the condition and require airway management during surgery. Children with syndromes, central sleep apnea, difficult airways, fentanyl allergy, cardiovascular issues, or pulmonary hypertension cannot participate.
What is being tested?
The trial is studying how Fentanyl Citrate affects breathing control in children with obstructive sleep apnea during surgery. It aims to understand if intermittent low oxygen levels change the way these kids respond to opioids like Fentanyl.
What are the potential side effects?
Fentanyl may cause slowed breathing, changes in blood pressure, nausea, itching or rash at the injection site. In some cases it can lead to excessive sedation or mood changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was intubated without receiving any sedatives like propofol.
Select...
I require an LMA or ETT for airway management.
Select...
I am scheduled for a tonsil or tonsil and adenoid removal surgery.
Select...
I have been diagnosed with obstructive sleep apnea through a sleep study.
Select...
I am between 2 and 8 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have high blood pressure in the lungs.
Select...
I need to be fully asleep with IV anesthesia for my procedure.
Select...
My parents have refused participation.
Select...
I do not have obstructive sleep apnea.
Select...
I will be given anesthesia through an IV.
Select...
I am taking medication for heart conditions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end tidal co2 measured at each minute for 10 consecutive minutes following opioid administration
This trial's timeline: 3 weeks for screening, Varies for treatment, and end tidal co2 measured at each minute for 10 consecutive minutes following opioid administration for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Respiratory depression following opioids

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Patients with sleep apnea having oxygen Saturation >85%Active Control1 Intervention
Children with OSA having procedures requiring endotracheal intubation and an who will receive opioids for evaluation of respiratory changes
Group II: Patients with sleep apnea having oxygen Saturation <85%Active Control1 Intervention
Children without OSA having procedures requiring endotracheal intubation and an who will receive opioids for evaluation of respiratory changes

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor
1,024 Previous Clinical Trials
6,029,380 Total Patients Enrolled
University of HoustonOTHER
150 Previous Clinical Trials
47,789 Total Patients Enrolled
Children's Hospital of PhiladelphiaOTHER
729 Previous Clinical Trials
8,470,132 Total Patients Enrolled

Media Library

Fentanyl Citrate (Opioid Analgesic) Clinical Trial Eligibility Overview. Trial Name: NCT05051189 — Phase < 1
Obstructive Sleep Apnea Research Study Groups: Patients with sleep apnea having oxygen Saturation >85%, Patients with sleep apnea having oxygen Saturation <85%
Obstructive Sleep Apnea Clinical Trial 2023: Fentanyl Citrate Highlights & Side Effects. Trial Name: NCT05051189 — Phase < 1
Fentanyl Citrate (Opioid Analgesic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05051189 — Phase < 1
~33 spots leftby Nov 2025